Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”)

In this briefing: Event Driven: Decoding HUL’s Ice Cream Demerger and Kwality Wall’s Muted Debut HSIE Results Daily: ONGC, Petronet LNG, Indraprastha Gas PI Industries Ltd - Near-Term Headwinds Persist; Maintain HOLD Praj Industries Ltd - Bio-Energy Headwinds Persist; Signs of Growth in Other Businesses Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth 1. Event Driven: Decoding HUL’s Ice Cream Demerger and Kwality Wall’s Muted Debut As Hindustan Unilever (HUVR IN) demerged ice cream entity, Kwality Wall’s faces a mandatory open offer from parent Unilever PLC (ULVR LN) subsidiary Magnum HoldCo to consolidate its controlling stake The stock listed at a 25% percent discount as investors flagged low margins and high capital intensity compared to peers Management justifies the split citing the business's distinct cold-chain operating model and the need for independent capital allocation to drive growth 2. HSIE Results Daily: ONGC, Petronet LNG, Indraprastha Gas ONGC: We maintain our REDUCE rating on ONGC, with a target price of INR 220 as we expect slower ramp-up in oil & gas production Q3FY26 quarter’s reported EBITDA at ~INR 173bn (-8.7% YoY, -2.1% QoQ) and PAT at ~INR 84bn (+1.6% YoY, -15.0% QoQ) were marginally lower than our estimates due to lower-than-expected crude oil production volume Petronet LNG: Our REDUCE recommendation on Petronet LNG (PLNG) with a revised TP of INR 275 is based on (1) muted volume growth, (2) delayed capacity expansion, and (3) subdued return ratios resulting from the high capex cycle expected in the next five years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: HSIE Results Daily: ONGC, Petronet LNG, Indraprastha Gas PI Industries Ltd - Near-Term Headwinds Persist; Maintain HOLD Praj Industries Ltd - Bio-Energy Headwinds Persist; Signs of Growth in Other Businesses Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth Endurance Technologies Ltd - Strong Order Wins & Strategic Capex; Margin Upside Largely Priced In 1. HSIE Results Daily: ONGC, Petronet LNG, Indraprastha Gas ONGC: We maintain our REDUCE rating on ONGC, with a target price of INR 220 as we expect slower ramp-up in oil & gas production Q3FY26 quarter’s reported EBITDA at ~INR 173bn (-8.7% YoY, -2.1% QoQ) and PAT at ~INR 84bn (+1.6% YoY, -15.0% QoQ) were marginally lower than our estimates due to lower-than-expected crude oil production volume Petronet LNG: Our REDUCE recommendation on Petronet LNG (PLNG) with a revised TP of INR 275 is based on (1) muted volume growth, (2) delayed capacity expansion, and (3) subdued return ratios resulting from the high capex cycle expected in the next five years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Hybridan Small Cap Feast: 9 February 2026 PI Industries Ltd - Near-Term Headwinds Persist; Maintain HOLD Praj Industries Ltd - Bio-Energy Headwinds Persist; Signs of Growth in Other Businesses Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth Endurance Technologies Ltd - Strong Order Wins & Strategic Capex; Margin Upside Largely Priced In 1. Hybridan Small Cap Feast: 9 February 2026 Arecor Therapeutics 80.00p £29.26m (AREC.L) The biopharmaceutical Company focused on drug development and enhanced delivery in diabetes and other cardiometabolic diseases provided a business update for the 12 months ended 31 December 2025. The Company continued focus on two core product areas: diabetes and oral delivery of peptides. A codevelopment deal was signed in September 2025 with Sequel Med Tech to combine Arecor's ultra-concentrated, ultra-rapid-acting (500U/mL) insulin AT278 with Sequel's twist Automated Insulin Delivery (AID) system. 2. PI Industries Ltd - Near-Term Headwinds Persist; Maintain HOLD Domestic Businesses Impacted by Short-term Challenges: The domestic business reported an 8% YoY revenue decline in Q3FY26, with volumes down 2%, impacted by subdued farmer offtake for high-value products.

In this briefing: Praj Industries Ltd - Bio-Energy Headwinds Persist; Signs of Growth in Other Businesses Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth Endurance Technologies Ltd - Strong Order Wins & Strategic Capex; Margin Upside Largely Priced In Inox Wind Ltd - Q3 Miss on All Fronts Against Consensus VIP Industries Ltd - Near-Term Challenges Continue; Maintain HOLD 1. Praj Industries Ltd - Bio-Energy Headwinds Persist; Signs of Growth in Other Businesses Bio-energy Slowdown Continues: The company’s 1G Ethanol business continues to remain impacted by subdued demand and an extended execution cycle. However, management is witnessing good traction in brownfield projects focused on operational efficiency and value-added product additions. Margin Deteriorating: EBITDA margins declined during the quarter, primarily due to lower export revenue. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth Endurance Technologies Ltd - Strong Order Wins & Strategic Capex; Margin Upside Largely Priced In Inox Wind Ltd - Q3 Miss on All Fronts Against Consensus VIP Industries Ltd - Near-Term Challenges Continue; Maintain HOLD Hesai Group (HSAI US) - Structural Growth Story Remains Intact 1. Camlin Fine Sciences Ltd. - Blends Steady; Vanillin Poised for Realisation-Driven Growth Vanillin – Core Growth Driver: The Vanillin segment witnessed a 4% YoY revenue decline, as the management consciously curtailed dispatches (490 tonnes) in anticipation of a 25% reduction in US import duties. This strategic deferment is expected to enhance realisations by approximately $2–3/kg (to $14–14.5/kg) in subsequent quarters following the duty reduction. For Q4FY26, the company has guided for 600–700 tonnes of sales volume (300–350 tonnes from the US). Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Indian markets ended the week slightly higher despite volatility, with the Nifty reclaiming 26,300 before settling above 26,200. InCred Equities released its latest high-conviction picks, highlighting 10 stocks with notable upside potential. Camlin Fine Sciences leads the list with a projected gain of 187%, followed by strong opportunities across varied sectors

Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. Further to the announcements made on March 13, June 24, September 29, and November 25, CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients,

MUMBAI, India--(BUSINESS WIRE)--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan. CAMLIN FINE SCIENCES LIMITED, a leading Indian group in shelf life solutions for flavour and health & wellness ingredients, listed on the National Stock Exchange of India Ltd and BSE Ltd. in Mumbai India (“CFSL”) reminds that CFSL and the majority shareholders (the “Sellers”)